Skip to main content
. 2020 Jul 23;405(6):833–842. doi: 10.1007/s00423-020-01939-3

Table 1.

Preoperative baseline characteristics of study population

ADPKD group
(n = 193)
Matched control group
(n = 193)
p value
Donor characteristics
*Donor age (years) 53.0 (95% CI 51.0–56.0) 57.0 (95% CI 54.0–60.0) 0.1744
Donor gender (female/male) 98 (50.8%)/95 (49.2%) 86 (44.6%)/107 (55.4%) 0.2623
Donor BMI (kg/m2) 25.6 (95% CI 24.8–26.1) 25.3 (95% CI 24.7–25.9) 0.3551
Recipient characteristics
*Recipient age (years) 54.6 (95% CI 53.0–56.2) 55.7 (95% CI 53.0–59.1) 0.7703
Recipient gender (female/male) 88 (45.6%)/105 (54.4%) 61 (31.6%)/132 (68.4%) 0.0065
Recipient BMI (kg/m2) 25.1 (95% CI 24.6–26.2) 25.2 (95% CI 24.7–25.9) 0.9309
ASA status recipient (in %)

1

2

3

4

0 (0.0%)

63 (32.6%)

122 (63.2%)

8 (4.2%)

1 (0.5%)

54 (28.0%)

130 (67.4%)

8 (4.2%)

1.0000

0.3757

0.4543

1.0000

*Time on dialysis (in d) 964 (95% CI 577.0–1345.4) 909 (95% CI 719.4–1229.7) 0.8064
Transplant characteristics
*Type of transplantation (in %)

Cadaveric

ABOc (living)

ABOi (living)

96 (49.7%)

75 (38.9%)

22 (11.4%)

94 (48.7%)

76 (39.4%)

23 (11.9%)

0.9189

1.0000

1.0000

*Cold ischemic time (in min.) 328.0 (95% CI 216.0–436.6) 278.0 (95% CI 181.4–435.4) 0.1088
*Year of transplantation 2008 (95% CI 2007–2009) 2008 (95% 2007–2009) 0.2102
Immunological characteristics
*No. of transplantation (in %)

1st

2nd

3rd

187 (96.9%)

6 (3.1%)

0 (0.0%)

184 (95.3%)

7 (3.6%)

2 (1.0%)

0.5999

1.0000

0.4987

*Panel reactive antibodies (in %) 0.0 (95% CI 0.0–0.0) 0.0 (95% CI 0.0–0.0) 0.6927
*HLA-Mismatches (no. of mismatches) 3.0 (95% CI 3.0–4.0) 3.0 (95% CI 3.0–3.0) 0.2351

Data are n (%) or median ± 95% CI. p values are estimated with Mann-Whitney U test for calculated data, and 2-tailed Fisher’s exact test for categorical data

*propensity score-based match criteria